GO:0042789 | mRNA transcription from RNA polymerase II promoter | 2.09e-05 | 3.02e-01 | 8.116 | 2 | 2 | 13 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0023057 | negative regulation of signaling | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:2000016 | negative regulation of determination of dorsal identity | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0072376 | protein activation cascade | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0051435 | BH4 domain binding | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0009786 | regulation of asymmetric cell division | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0060913 | cardiac cell fate determination | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0005654 | nucleoplasm | 1.73e-03 | 1.00e+00 | 2.737 | 4 | 64 | 1082 |
GO:0007021 | tubulin complex assembly | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0038127 | ERBB signaling pathway | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0001714 | endodermal cell fate specification | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0044212 | transcription regulatory region DNA binding | 3.61e-03 | 1.00e+00 | 4.424 | 2 | 17 | 168 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 7 |
GO:0001955 | blood vessel maturation | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 1 | 8 |
GO:0007172 | signal complex assembly | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 1 | 8 |
GO:0060396 | growth hormone receptor signaling pathway | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 1 | 8 |
GO:0006983 | ER overload response | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 9 |
GO:0031953 | negative regulation of protein autophosphorylation | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 9 |
GO:0005832 | chaperonin-containing T-complex | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 2 | 9 |
GO:0002199 | zona pellucida receptor complex | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 2 | 10 |
GO:0035413 | positive regulation of catenin import into nucleus | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 2 | 10 |
GO:0045662 | negative regulation of myoblast differentiation | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 3 | 11 |
GO:0017166 | vinculin binding | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 4 | 11 |
GO:0005838 | proteasome regulatory particle | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 12 |
GO:0030234 | enzyme regulator activity | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 2 | 13 |
GO:0008134 | transcription factor binding | 7.34e-03 | 1.00e+00 | 3.897 | 2 | 18 | 242 |
GO:0034614 | cellular response to reactive oxygen species | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 2 | 14 |
GO:0000242 | pericentriolar material | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 14 |
GO:0005874 | microtubule | 7.76e-03 | 1.00e+00 | 3.856 | 2 | 7 | 249 |
GO:0001824 | blastocyst development | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 2 | 15 |
GO:0043274 | phospholipase binding | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 1 | 16 |
GO:0042176 | regulation of protein catabolic process | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 2 | 16 |
GO:0022624 | proteasome accessory complex | 9.39e-03 | 1.00e+00 | 6.729 | 1 | 1 | 17 |
GO:0032757 | positive regulation of interleukin-8 production | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 1 | 20 |
GO:0005515 | protein binding | 1.12e-02 | 1.00e+00 | 1.067 | 7 | 198 | 6024 |
GO:0048041 | focal adhesion assembly | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 21 |
GO:0005720 | nuclear heterochromatin | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 2 | 22 |
GO:0019901 | protein kinase binding | 1.24e-02 | 1.00e+00 | 3.508 | 2 | 18 | 317 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 1.27e-02 | 1.00e+00 | 6.293 | 1 | 1 | 23 |
GO:0007339 | binding of sperm to zona pellucida | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 2 | 25 |
GO:0051209 | release of sequestered calcium ion into cytosol | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 1 | 26 |
GO:0043565 | sequence-specific DNA binding | 1.46e-02 | 1.00e+00 | 3.381 | 2 | 11 | 346 |
GO:0048754 | branching morphogenesis of an epithelial tube | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 1 | 27 |
GO:0007017 | microtubule-based process | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 2 | 27 |
GO:0051258 | protein polymerization | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 2 | 27 |
GO:0005875 | microtubule associated complex | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 1 | 28 |
GO:0030032 | lamellipodium assembly | 1.60e-02 | 1.00e+00 | 5.958 | 1 | 1 | 29 |
GO:0044822 | poly(A) RNA binding | 1.66e-02 | 1.00e+00 | 2.357 | 3 | 50 | 1056 |
GO:0042594 | response to starvation | 1.71e-02 | 1.00e+00 | 5.862 | 1 | 4 | 31 |
GO:0034446 | substrate adhesion-dependent cell spreading | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 2 | 36 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.03e-02 | 1.00e+00 | 5.607 | 1 | 5 | 37 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.10e-02 | 1.00e+00 | 3.105 | 2 | 30 | 419 |
GO:0035019 | somatic stem cell maintenance | 2.20e-02 | 1.00e+00 | 5.494 | 1 | 6 | 40 |
GO:0031124 | mRNA 3'-end processing | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 2 | 42 |
GO:0006369 | termination of RNA polymerase II transcription | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 2 | 45 |
GO:0043525 | positive regulation of neuron apoptotic process | 2.52e-02 | 1.00e+00 | 5.293 | 1 | 4 | 46 |
GO:0044297 | cell body | 2.52e-02 | 1.00e+00 | 5.293 | 1 | 2 | 46 |
GO:0044267 | cellular protein metabolic process | 2.65e-02 | 1.00e+00 | 2.927 | 2 | 20 | 474 |
GO:0001669 | acrosomal vesicle | 2.69e-02 | 1.00e+00 | 5.201 | 1 | 2 | 49 |
GO:0006521 | regulation of cellular amino acid metabolic process | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 1 | 50 |
GO:0006986 | response to unfolded protein | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 4 | 50 |
GO:0034976 | response to endoplasmic reticulum stress | 2.79e-02 | 1.00e+00 | 5.144 | 1 | 2 | 51 |
GO:0045454 | cell redox homeostasis | 2.79e-02 | 1.00e+00 | 5.144 | 1 | 1 | 51 |
GO:0051028 | mRNA transport | 2.85e-02 | 1.00e+00 | 5.116 | 1 | 4 | 52 |
GO:0009611 | response to wounding | 2.85e-02 | 1.00e+00 | 5.116 | 1 | 5 | 52 |
GO:0001725 | stress fiber | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 4 | 55 |
GO:0005643 | nuclear pore | 3.12e-02 | 1.00e+00 | 4.983 | 1 | 11 | 57 |
GO:0000502 | proteasome complex | 3.17e-02 | 1.00e+00 | 4.958 | 1 | 3 | 58 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 3.23e-02 | 1.00e+00 | 4.933 | 1 | 6 | 59 |
GO:0005737 | cytoplasm | 3.28e-02 | 1.00e+00 | 1.259 | 5 | 124 | 3767 |
GO:0008013 | beta-catenin binding | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 9 | 60 |
GO:0006406 | mRNA export from nucleus | 3.33e-02 | 1.00e+00 | 4.885 | 1 | 4 | 61 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 3.33e-02 | 1.00e+00 | 4.885 | 1 | 2 | 61 |
GO:0019903 | protein phosphatase binding | 3.39e-02 | 1.00e+00 | 4.862 | 1 | 2 | 62 |
GO:0005829 | cytosol | 3.48e-02 | 1.00e+00 | 1.531 | 4 | 86 | 2496 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 3.50e-02 | 1.00e+00 | 4.816 | 1 | 1 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 2 | 65 |
GO:0010468 | regulation of gene expression | 3.71e-02 | 1.00e+00 | 4.729 | 1 | 2 | 68 |
GO:0034329 | cell junction assembly | 3.71e-02 | 1.00e+00 | 4.729 | 1 | 3 | 68 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.82e-02 | 1.00e+00 | 4.687 | 1 | 2 | 70 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 3.93e-02 | 1.00e+00 | 4.646 | 1 | 1 | 72 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 4.03e-02 | 1.00e+00 | 4.607 | 1 | 4 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.03e-02 | 1.00e+00 | 4.607 | 1 | 2 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 4.09e-02 | 1.00e+00 | 4.587 | 1 | 1 | 75 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 4.09e-02 | 1.00e+00 | 4.587 | 1 | 1 | 75 |
GO:0007229 | integrin-mediated signaling pathway | 4.25e-02 | 1.00e+00 | 4.531 | 1 | 3 | 78 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 4.30e-02 | 1.00e+00 | 4.512 | 1 | 2 | 79 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 4.30e-02 | 1.00e+00 | 4.512 | 1 | 2 | 79 |
GO:0009653 | anatomical structure morphogenesis | 4.51e-02 | 1.00e+00 | 4.441 | 1 | 2 | 83 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 4.67e-02 | 1.00e+00 | 4.390 | 1 | 8 | 86 |
GO:0006936 | muscle contraction | 4.73e-02 | 1.00e+00 | 4.373 | 1 | 3 | 87 |
GO:0000187 | activation of MAPK activity | 4.89e-02 | 1.00e+00 | 4.324 | 1 | 3 | 90 |
GO:0007010 | cytoskeleton organization | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 4 | 91 |
GO:0006928 | cellular component movement | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 3 | 91 |
GO:0005200 | structural constituent of cytoskeleton | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 6 | 91 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 4.99e-02 | 1.00e+00 | 4.293 | 1 | 1 | 92 |
GO:0010467 | gene expression | 4.99e-02 | 1.00e+00 | 2.430 | 2 | 45 | 669 |
GO:0005770 | late endosome | 5.04e-02 | 1.00e+00 | 4.277 | 1 | 2 | 93 |
GO:0051082 | unfolded protein binding | 5.04e-02 | 1.00e+00 | 4.277 | 1 | 7 | 93 |
GO:0005178 | integrin binding | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 4 | 96 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 5.41e-02 | 1.00e+00 | 2.367 | 2 | 39 | 699 |
GO:0008360 | regulation of cell shape | 5.57e-02 | 1.00e+00 | 4.130 | 1 | 4 | 103 |
GO:0005938 | cell cortex | 5.63e-02 | 1.00e+00 | 4.116 | 1 | 5 | 104 |
GO:0030529 | ribonucleoprotein complex | 6.05e-02 | 1.00e+00 | 4.009 | 1 | 5 | 112 |
GO:0000209 | protein polyubiquitination | 6.26e-02 | 1.00e+00 | 3.958 | 1 | 3 | 116 |
GO:0007050 | cell cycle arrest | 6.68e-02 | 1.00e+00 | 3.862 | 1 | 5 | 124 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 6.72e-02 | 1.00e+00 | 2.192 | 2 | 41 | 789 |
GO:0030027 | lamellipodium | 6.73e-02 | 1.00e+00 | 3.850 | 1 | 7 | 125 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 6.88e-02 | 1.00e+00 | 3.816 | 1 | 11 | 128 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 7.09e-02 | 1.00e+00 | 3.772 | 1 | 4 | 132 |
GO:0016055 | Wnt signaling pathway | 7.40e-02 | 1.00e+00 | 3.708 | 1 | 4 | 138 |
GO:0006457 | protein folding | 7.66e-02 | 1.00e+00 | 3.656 | 1 | 7 | 143 |
GO:0000082 | G1/S transition of mitotic cell cycle | 7.97e-02 | 1.00e+00 | 3.597 | 1 | 3 | 149 |
GO:0042981 | regulation of apoptotic process | 8.03e-02 | 1.00e+00 | 3.587 | 1 | 4 | 150 |
GO:0006974 | cellular response to DNA damage stimulus | 8.08e-02 | 1.00e+00 | 3.578 | 1 | 7 | 151 |
GO:0000398 | mRNA splicing, via spliceosome | 8.74e-02 | 1.00e+00 | 3.459 | 1 | 15 | 164 |
GO:0034641 | cellular nitrogen compound metabolic process | 9.10e-02 | 1.00e+00 | 3.398 | 1 | 2 | 171 |
GO:0016607 | nuclear speck | 9.15e-02 | 1.00e+00 | 3.390 | 1 | 12 | 172 |
GO:0005667 | transcription factor complex | 9.31e-02 | 1.00e+00 | 3.365 | 1 | 17 | 175 |
GO:0031625 | ubiquitin protein ligase binding | 9.46e-02 | 1.00e+00 | 3.340 | 1 | 5 | 178 |
GO:0003714 | transcription corepressor activity | 9.46e-02 | 1.00e+00 | 3.340 | 1 | 11 | 178 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 1.00e-01 | 1.00e+00 | 3.254 | 1 | 5 | 189 |
GO:0006355 | regulation of transcription, DNA-templated | 1.01e-01 | 1.00e+00 | 1.855 | 2 | 43 | 997 |
GO:0003924 | GTPase activity | 1.04e-01 | 1.00e+00 | 3.194 | 1 | 7 | 197 |
GO:0006184 | GTP catabolic process | 1.13e-01 | 1.00e+00 | 3.075 | 1 | 7 | 214 |
GO:0016071 | mRNA metabolic process | 1.17e-01 | 1.00e+00 | 3.015 | 1 | 8 | 223 |
GO:0008380 | RNA splicing | 1.20e-01 | 1.00e+00 | 2.983 | 1 | 22 | 228 |
GO:0016070 | RNA metabolic process | 1.29e-01 | 1.00e+00 | 2.868 | 1 | 8 | 247 |
GO:0070062 | extracellular vesicular exosome | 1.34e-01 | 1.00e+00 | 1.172 | 3 | 57 | 2400 |
GO:0000166 | nucleotide binding | 1.35e-01 | 1.00e+00 | 2.799 | 1 | 13 | 259 |
GO:0003677 | DNA binding | 1.42e-01 | 1.00e+00 | 1.566 | 2 | 49 | 1218 |
GO:0005856 | cytoskeleton | 1.50e-01 | 1.00e+00 | 2.631 | 1 | 9 | 291 |
GO:0005525 | GTP binding | 1.60e-01 | 1.00e+00 | 2.540 | 1 | 12 | 310 |
GO:0005813 | centrosome | 1.67e-01 | 1.00e+00 | 2.467 | 1 | 7 | 326 |
GO:0008283 | cell proliferation | 1.68e-01 | 1.00e+00 | 2.459 | 1 | 14 | 328 |
GO:0015031 | protein transport | 1.74e-01 | 1.00e+00 | 2.402 | 1 | 11 | 341 |
GO:0003723 | RNA binding | 1.75e-01 | 1.00e+00 | 2.398 | 1 | 18 | 342 |
GO:0005925 | focal adhesion | 1.86e-01 | 1.00e+00 | 2.300 | 1 | 9 | 366 |
GO:0007155 | cell adhesion | 1.87e-01 | 1.00e+00 | 2.289 | 1 | 5 | 369 |
GO:0046982 | protein heterodimerization activity | 1.92e-01 | 1.00e+00 | 2.246 | 1 | 8 | 380 |
GO:0000278 | mitotic cell cycle | 1.97e-01 | 1.00e+00 | 2.205 | 1 | 15 | 391 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.07e-01 | 1.00e+00 | 2.126 | 1 | 24 | 413 |
GO:0043066 | negative regulation of apoptotic process | 2.12e-01 | 1.00e+00 | 2.088 | 1 | 16 | 424 |
GO:0005634 | nucleus | 2.24e-01 | 1.00e+00 | 0.662 | 4 | 159 | 4559 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.36e-01 | 1.00e+00 | 1.915 | 1 | 24 | 478 |
GO:0016020 | membrane | 2.37e-01 | 1.00e+00 | 1.101 | 2 | 46 | 1681 |
GO:0048471 | perinuclear region of cytoplasm | 2.47e-01 | 1.00e+00 | 1.845 | 1 | 8 | 502 |
GO:0016032 | viral process | 2.61e-01 | 1.00e+00 | 1.755 | 1 | 26 | 534 |
GO:0006915 | apoptotic process | 2.69e-01 | 1.00e+00 | 1.700 | 1 | 12 | 555 |
GO:0005794 | Golgi apparatus | 2.92e-01 | 1.00e+00 | 1.563 | 1 | 9 | 610 |
GO:0007165 | signal transduction | 4.05e-01 | 1.00e+00 | 0.991 | 1 | 13 | 907 |
GO:0008270 | zinc ion binding | 4.36e-01 | 1.00e+00 | 0.855 | 1 | 27 | 997 |
GO:0044281 | small molecule metabolic process | 5.04e-01 | 1.00e+00 | 0.574 | 1 | 20 | 1211 |
GO:0005524 | ATP binding | 5.30e-01 | 1.00e+00 | 0.474 | 1 | 31 | 1298 |
GO:0005730 | nucleolus | 6.20e-01 | 1.00e+00 | 0.136 | 1 | 66 | 1641 |
GO:0005886 | plasma membrane | 7.94e-01 | 1.00e+00 | -0.518 | 1 | 49 | 2582 |